We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics drives ILC2s function and fatty acid metabolism in allergic airway inflammation via PPARγ signaling
Summary
Researchers found that microplastics exacerbate allergic airway inflammation in house dust mite-sensitized mice by promoting epithelial barrier disruption and type 2 immune activation. The study revealed that microplastics drive the function of innate lymphoid cells (ILC2s) and alter fatty acid metabolism through the PPARgamma signaling pathway, providing mechanistic insight into how airborne microplastics may worsen respiratory allergies.
Microplastics (MPs), emerging airborne pollutants detected in human lungs, are increasingly recognized as potential drivers of respiratory disease, yet their roles and pathogenic mechanisms in allergic airway inflammation remain poorly understood. Here we show that MPs exacerbate allergic airway inflammation in house dust mite (HDM)-sensitized mice by promoting epithelial barrier disruption and type 2 immune activation. MPs exposure elevated IL-33 release and expanded IL-5⁺IL-13⁺ ILC2s. Mechanistically, the Peroxisome proliferator-activated receptor gamma (PPARγ) was markedly expressed in MPs+HDM mice and is highly expressed in ILC2s. In epithelial-ILC2s coculture system, MPs selectively enhanced PPARγ expression in ILC2s, triggering metabolic reprogramming characterized by increased fatty acid uptake and lipid droplet accumulation. This metabolic shift fueled ILC2s activation, cytokine production and downstream ST2 activation, while pharmacological inhibition of PPARγ effectively attenuated these effects. Our findings identify a previously unrecognized epithelial-PPARγ-ILC2s axis through which MPs aggravate allergic airway inflammation, revealing a potential immunometabolic mechanism of MPs-induced lung impairment.
Sign in to start a discussion.
More Papers Like This
Co-exposure to polyethylene microplastics and house dust mites aggravates airway epithelial barrier dysfunction and airway inflammation via CXCL1 signaling pathway in a mouse model
In a mouse model of asthma, co-exposure to inhaled polyethylene microplastics and house dust mite allergens caused worse airway inflammation than either pollutant alone. The microplastics damaged the airway lining and amplified allergic reactions through a specific inflammatory signaling pathway called CXCL1. This finding suggests that breathing in airborne microplastics could make allergies and asthma worse by helping allergens penetrate deeper into the lungs.
Cellular and molecular mechanisms of allergic asthma
Researchers reviewed the cellular and molecular mechanisms behind allergic asthma, finding that rising exposure to environmental pollutants — including microplastics — likely contributes to the disease's increasing prevalence, as pollutants disrupt airway barrier integrity and trigger immune responses that lead to chronic airway inflammation.
Effects of microplastics on allergic airways and potential pathogenesis: a review
This review examines how microplastics, which can enter the body through breathing, eating, and skin contact, may affect allergic airway conditions. Researchers found evidence that microplastics can damage airway lining cells, disrupt the protective barrier of the respiratory tract, and trigger heightened airway reactivity. The study suggests that chronic microplastic exposure may worsen allergic airway inflammation, though more research is needed to fully understand the mechanisms involved.
Impact of Microplastic Exposure on Airway Inflammation in an Acute Asthma Murine Model
Mouse experiments found that microplastic exposure worsened inflammatory responses in healthy lungs but did not further aggravate airway inflammation in mice with pre-existing asthma, suggesting the lung's response to microplastics depends on baseline immune state.
The Impact of Microplastics on Allergy: Current Status and Future Research Directions
This study reviews current evidence on how microplastics may influence allergic responses, noting that microplastics can compromise epithelial barriers and promote type 2 inflammation associated with allergies. The authors emphasize an urgent need for research into dose-dependent immunotoxicological mechanisms to better understand the relationship between microplastic exposure and allergy development. The study calls for evidence-based policies to reduce microplastic exposure and its potential contribution to the growing allergy burden.